Two Sigma Advisers
RPTP

Two Sigma Advisers’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Two Sigma Advisers’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-75,713
Closed -$1.2M – 2203
2015
Q2 		$1.2M Buy
+75,713
New +$920K 0.01% 1044
2014
Q3 		– Sell
-10,700
Closed -$124K – 2982
2014
Q2 		$124K Buy
+10,700
New +$97.4K ﹤0.01% 2340

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Two Sigma Advisers's RPTP Position: Q3 2015 in Review

Two Sigma Advisers sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2015, closing a stake of 75,713 shares — an estimated $1.2M sold.

Two Sigma Advisers first reported a position in RPTP in Q2 2014 and held it in 2 quarters. The position peaked at $1.2M in Q2 2015. 106 funds tracked by Wall St. Rank hold RPTP as of Q3 2015.

  • Two Sigma Advisers reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2015 after selling out during the quarter.
  • Two Sigma Advisers sold 75,713 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2015, an estimated $1.2M.
  • Two Sigma Advisers first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2014 and held it in 2 quarters.
  • Two Sigma Advisers's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.2M in Q2 2015.
  • 106 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2015.

Based on Two Sigma Advisers's 13F filing for Q3 2015, filed 16 Nov 2015.